Structural Interventions
The Amplatzer™ portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The procedures are performed through a minimally invasive, transcatheter approach, which prevents the need for open heart surgery and helps facilitate faster recovery and lower complication rates. The Amplatzer line has built a reputation for innovation by pioneering structural heart defect occluder devices and remains the leader in treatment worldwide.
Structural Interventions
The Amplatzer™ portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The procedures are performed through a minimally invasive, transcatheter approach, which prevents the need for open heart surgery and helps facilitate faster recovery and lower complication rates. The Amplatzer line has built a reputation for innovation by pioneering structural heart defect occluder devices and remains the leader in treatment worldwide.

AMPLATZER™ AMULET™ LAA OCCLUDER
STROKE RISK REDUCTION
The Amplatzer Amulet LAA Occluder is designed to treat patients with atrial fibrillation who are at risk of ischemic stroke. The device offers immediate closure1 of the left atrial appendage (LAA), reducing the risk of stroke and immediately eliminating the need for oral anticoagulants.2
AMPLATZER™ TALISMAN™ PFO OCCLUDER
STROKE RISK REDUCTION
The Amplatzer PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke.3 The Amplatzer Talisman PFO Occluder is built off this proven technology, with key enhancements to make it our most advanced and easy-to-use PFO closure device yet. With over 180,000 devices implanted worldwide,2 we are the leader in PFO closure.


AMPLATZER™ TALISMAN™ PFO OCCLUDER
STROKE RISK REDUCTION
The Amplatzer PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke.3 The Amplatzer Talisman PFO Occluder is built off this proven technology, with key enhancements to make it our most advanced and easy-to-use PFO closure device yet. With over 180,000 devices implanted worldwide,2 we are the leader in PFO closure.

AMPLATZER™ SEPTAL OCCLUDER
CONGENITAL DEFECTS
The Amplatzer Septal Occluder is the standard of care for minimally invasive atrial septal defect (ASD) closure, with a variety of shapes, sizes, and features that facilitate precise placement. It is the most studied ASD closure device available today, with over 20 years of demonstrated clinical experience.4,5
AMPLATZER™ DUCT OCCLUDERS
CONGENITAL DEFECTS
The Amplatzer family of duct occluders offers an extensive line of devices for the closure of patent ductus arteriosus (PDA). Amplatzer Duct Occluders are designed to occlude PDAs of various shapes and sizes to meet the needs of your patients.


AMPLATZER™ DUCT OCCLUDERS
CONGENITAL DEFECTS
The Amplatzer family of duct occluders offers an extensive line of devices for the closure of patent ductus arteriosus (PDA). Amplatzer Duct Occluders are designed to occlude PDAs of various shapes and sizes to meet the needs of your patients.

AMPLATZER™ MUSCULAR VSD OCCLUDERS
CONGENITAL DEFECTS
Ventricular septal defects (VSD) are the most common congenital heart defect,6 and one subtype of these defects is muscular VSD. The Amplatzer Muscular VSD Occluders are designed for complete closure of these type of defects.
MAT-2114949 v1.0 | Item approved for U.S. use only.